[NKTR] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -35.73%
YoY- -9.90%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 28,330 23,647 23,462 30,033 48,847 50,573 33,862 -11.22%
PBT -125,162 -122,875 -117,075 -108,565 -79,856 -138,451 -111,886 7.76%
Tax 357 92 128 21 144 200 278 18.16%
NP -125,519 -122,967 -117,203 -108,586 -80,000 -138,651 -112,164 7.79%
Tax Rate - - - - - - - -
Total Cost 153,849 146,614 140,665 138,619 128,847 189,224 146,026 3.54%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -443.06 -520.01 -499.54 -361.56 -163.78 -274.16 -331.24 21.41%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.69 -0.68 -0.65 -0.61 -0.45 -0.78 -0.64 5.14%
EPS Diluted -0.69 -0.68 -0.65 -0.61 -0.45 -0.78 -0.64 5.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.